Published in Neuroimage on December 28, 2011
MR imaging of oxygen extraction and neurovascular coupling. Stroke (2013) 0.95
Inner retinal oxygen extraction fraction in rat. Invest Ophthalmol Vis Sci (2013) 0.89
The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab (2012) 0.84
Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies. Cell Mol Life Sci (2015) 0.76
Mapping the dynamics of brain perfusion using functional ultrasound in a rat model of transient middle cerebral artery occlusion. J Cereb Blood Flow Metab (2015) 0.75
PET quantification of cerebral oxygen metabolism in small animals. ScientificWorldJournal (2014) 0.75
Multiparametric Magnetic Resonance Imaging for Prediction of Parenchymal Hemorrhage in Acute Ischemic Stroke After Reperfusion Therapy. Stroke (2017) 0.75
History and future technical innovation in positron emission tomography. J Med Imaging (Bellingham) (2017) 0.75
In vivo electron paramagnetic resonance oximetry and applications in the brain. Med Gas Res (2017) 0.75
The design and implementation of a motion correction scheme for neurological PET. Phys Med Biol (2003) 1.98
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet Neurol (2013) 1.82
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol (2004) 1.53
Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature. Cancer Treat Rev (2011) 1.52
Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. J Clin Oncol (2003) 1.51
A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin. J Drugs Dermatol (2002) 1.40
Establishment and functioning of intrathymic microenvironments. Immunol Rev (2006) 1.22
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis (2003) 1.16
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol (2007) 1.15
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. J Drugs Dermatol (2013) 1.14
Overexpression of ICAT highlights a role for catenin-mediated canonical Wnt signalling in early T cell development. Eur J Immunol (2006) 1.07
Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET. Eur J Pain (2004) 1.01
Metabolic activation of temozolomide measured in vivo using positron emission tomography. Cancer Res (2003) 1.01
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. J Drugs Dermatol (2005) 1.01
Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scans. J Nucl Med (2009) 0.93
Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients. Clin Cancer Res (2006) 0.93
Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Cancer (2011) 0.92
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis (2002) 0.91
Ultra staging to unmask the prescribing of adjuvant therapy in cancer patients: the future opportunity to image micrometastases using total-body 18F-FDG PET scanning. J Nucl Med (2014) 0.88
Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study. Cutis (2013) 0.87
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis (2005) 0.87
Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea. J Drugs Dermatol (2014) 0.87
Oncologic outcomes of transoral laser microsurgery for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Head Neck (2013) 0.85
The potential of positron-emission tomography to study anticancer-drug resistance. Nat Rev Cancer (2004) 0.85
Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drugs Dermatol (2007) 0.84
Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies. Cancer Res (2002) 0.83
Techniques for imaging neuroscience. Br Med Bull (2003) 0.80
Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue. Mol Cancer Ther (2009) 0.80
Molecular Imaging and Pharmacokinetic Analysis of Carbon-11 Labeled Antisense Oligonucleotide LY2181308 in Cancer Patients. Theranostics (2011) 0.80
2-[11C]thymidine positron emission tomography reproducibility in humans. Clin Cancer Res (2005) 0.79
Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers. Clin Cancer Res (2003) 0.79
Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study. J Drugs Dermatol (2014) 0.78
Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris. J Drugs Dermatol (2012) 0.78
Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidine. Biochim Biophys Acta (2004) 0.77
Realizing the full potential of PET for measuring the biodistribution of novel anticancer agents. J Nucl Med (2011) 0.77
Genetic diversity and population parameters of sea otters, Enhydra lutris, before fur trade extirpation from 1741-1911. PLoS One (2012) 0.75
Knocking out radiotracers for molecular imaging with PET. Drug Discov Today (2003) 0.75
Staffing Trends in Magnet and Non-Magnet Hospitals After State Legislation. J Nurs Care Qual (1) 0.75
Sexualized images of children on the Internet. Sex Abuse (2011) 0.75
Positron emission tomography (PET) and anticancer drug development. Discov Med (2004) 0.75
Evaluating the Performance of a Single-Item, Global, Estimate of Missed Nursing Care. J Nurs Meas (2017) 0.75
Student Preparation to Care for Dying Patients: Assessing Outcomes Across a Curriculum. J Nurs Educ (2017) 0.75
This edition includes 11 original articles covering an impressive wide range of topics. Introduction. Clin Otolaryngol (2015) 0.75
Molecular imaging: what picture does it paint for future oncology? Drug Discov Today (2002) 0.75
Tribute to Terry Jones: an interview by Val J. Halamandaris. Caring (2011) 0.75